期刊文献+

Low-dose interleukin-2 for the treatment of systemic lupus erythematosus with recurrent rash

原文传递
导出
摘要 To the Editor,Systemic lupus erythematosus(SLE)is a chronic autoimmune disease characterized by the production of autoantibodies against self-antigens,leading to widespread inflammation and multi-organ involvement.It can affect almost all organ systems,resulting in various clinical manifestations and numerous complications.1 Skin and mucosal lesions are observed in most patients with SLE.Typical manifestations include the characteristic butterflyshaped facial erythema,subacute cutaneous lupus,and chronic cutaneous lupus erythematosus,with other forms presenting as lupus panniculitis,chilblain lupus erythematosus,and discoid lupus erythematosus.2 Here,we report a case of a patient with persistent facial butterfly erythema that did not respond to standard treatments.
出处 《Rheumatology & Autoimmunity》 2024年第4期265-266,共2页 风湿病与自身免疫(英文)
基金 supported by a grant from the Municipal School Cooperative Research Special Project(Sichuan North Medical College)in Nanchong,Sichuan Province,Grant/Award Number:19SXHZ0140.
  • 相关文献

参考文献1

二级参考文献2

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部